Economic impact of pharmacist-led initiatives to minimize medication wastage costs in the hospital setting: an interrupted time series analysis
- 1Department of Hospital Pharmacy, Hospital of the University of Occupational and Environmental Health, 1-1, Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka 807-8556 Japan
- 2Department of Respiratory Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1, Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka 807-8555 Japan
- 3Second Department of Surgery, School of Medicine, University of Occupational and Environmental Health, 1-1, Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka 807-8555 Japan
Abstract
Background: Medication wastage poses significant economic challenges to hospital management worldwide. To address this issue, in October 2020, we implemented comprehensive pharmacist-led initiatives focusing specifically on expired drugs and high-cost medications. This study aimed to evaluate the long-term economic impact of these initiatives using an interrupted time series analysis.
Methods: The comprehensive pharmacist-led initiatives comprised five operational components: proactive deletion of dormant medications from the adoption list, standardization of return and exchange procedures, establishment of a “just-in-time” procurement category, targeted promotion of high-cost near-expiry drugs, and mandatory submission of “High-Cost Medication Waste Reports”. This study compared a 36-month pre-intervention period (October 2017 to September 2020) with a 48-month post-intervention period (October 2020 to September 2024). The primary outcome was the change in total monthly medication wastage costs, evaluated by level change and slope change. Cumulative cost savings over the 48-month post-intervention period were estimated by comparing observed costs with predicted counterfactual values. Secondary outcomes included wastage costs categorized by reason and changes in high-cost medication wastage (50,000 Japanese yen [JPY] or more per case).
Results: No significant level change was observed in total monthly medication wastage costs; however, the slope change was significant (β3 = -21,766 JPY/month; 95% confidence interval [CI]: -37,999 to -5,532; p = 0.0092). The estimated cumulative cost savings over the 48-month period following the intervention were 38,455,782 JPY. In the analysis by reason, expired drugs showed a significant slope change (β3 = -23,820 JPY/month; 95% CI, -34,530 to -13,111; p < 0.0001). For high-cost medications, we found significant reductions in wastage costs (β3 = -20,001 JPY/month; 95% CI, -35,864 to -4,137; p = 0.0141) and the frequency of wastage (incidence rate ratio = 0.977; 95% CI, 0.955 to 0.998; p = 0.0355).
Conclusions: Pharmacist-led initiatives focusing on expired and high-cost medications are economically effective, leading to a substantial reduction in hospital medication wastage costs. Pharmacists can enhance hospital financial sustainability by effectively mitigating avoidable medication-related economic losses.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s40780-026-00612-z.
Related
- A Structured, Auditable Taxonomy for Pharmacist-Identifiable Medication-Related Risk Signals in Routine Admission Data: A Retrospective Medication Safety Audit in a High-Risk Inpatient Cohort
- Adherence of HIV/AIDS patients following Medication Therapy Management and Pharmacist Counselling at a Public Hospital in Yogyakarta, Indonesia
- Beyond words: Enhancing medication understanding with pictograph-integrated pharmacist counseling in linguistically diverse patients
- Pharmacist-Led Comprehensive Medication Management and Patient Outcomes in Pediatric Intensive Care Unit Patients: A Multicenter Cohort Study
- Impact of clinical pharmacist interventions in psychiatric hospitals on clinical and medication-related outcomes: a systematic review and meta-analysis
BibTeX
@article{ueki2026economic,
title = {{Economic impact of pharmacist-led initiatives to minimize medication wastage costs in the hospital setting: an interrupted time series analysis}},
author = {Tetsuya Ueki and Hidehiro Kamachi and Mariko Oishi and Emiko Sanematsu and Shoko Ogata and Takaharu Ichiki and Kazuhiro Yatera and Fumihiro Tanaka},
journal = {Journal of Pharmaceutical Health Care and Sciences},
year = {2026},
month = jul,
doi = {10.1186/s40780-026-00612-z},
url = {https://doi.org/10.1186/s40780-026-00612-z},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Economic impact of pharmacist-led initiatives to minimize medication wastage costs in the hospital setting: an interrupted time series analysis
AU - Tetsuya Ueki
AU - Hidehiro Kamachi
AU - Mariko Oishi
AU - Emiko Sanematsu
AU - Shoko Ogata
AU - Takaharu Ichiki
AU - Kazuhiro Yatera
AU - Fumihiro Tanaka
PY - 2026
DA - 2026/07/28
JO - Journal of Pharmaceutical Health Care and Sciences
DO - 10.1186/s40780-026-00612-z
UR - https://doi.org/10.1186/s40780-026-00612-z
AB - Background: Medication wastage poses significant economic challenges to hospital management worldwide. To address this issue, in October 2020, we implemented comprehensive pharmacist-led initiatives focusing specifically on expired drugs and high-cost medications. This study aimed to evaluate the long-term economic impact of these initiatives using an interrupted time series analysis. Methods: The comprehensive pharmacist-led initiatives comprised five operational components: proactive deletion of dormant medications from the adoption list, standardization of return and exchange procedures, establishment of a “just-in-time” procurement category, targeted promotion of high-cost near-expiry drugs, and mandatory submission of “High-Cost Medication Waste Reports”. This study compared a 36-month pre-intervention period (October 2017 to September 2020) with a 48-month post-intervention period (October 2020 to September 2024). The primary outcome was the change in total monthly medication wastage costs, evaluated by level change and slope change. Cumulative cost savings over the 48-month post-intervention period were estimated by comparing observed costs with predicted counterfactual values. Secondary outcomes included wastage costs categorized by reason and changes in high-cost medication wastage (50,000 Japanese yen [JPY] or more per case). Results: No significant level change was observed in total monthly medication wastage costs; however, the slope change was significant (β3 = -21,766 JPY/month; 95% confidence interval [CI]: -37,999 to -5,532; p = 0.0092). The estimated cumulative cost savings over the 48-month period following the intervention were 38,455,782 JPY. In the analysis by reason, expired drugs showed a significant slope change (β3 = -23,820 JPY/month; 95% CI, -34,530 to -13,111; p < 0.0001). For high-cost medications, we found significant reductions in wastage costs (β3 = -20,001 JPY/month; 95% CI, -35,864 to -4,137; p = 0.0141) and the frequency of wastage (incidence rate ratio = 0.977; 95% CI, 0.955 to 0.998; p = 0.0355). Conclusions: Pharmacist-led initiatives focusing on expired and high-cost medications are economically effective, leading to a substantial reduction in hospital medication wastage costs. Pharmacists can enhance hospital financial sustainability by effectively mitigating avoidable medication-related economic losses. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s40780-026-00612-z.
SN - 2055-0294
ER -